The purpose of this research is to understand the impact of medically tailored meals on health-related biometrics (e.g., glucose time-in-range, waist-hip ratio, cholesterol) and how providing medically tailored meals promotes engagement in diabetes education and drives information-seeking behavior.
The purpose of this research is to understand the impact of medically tailored meals on health-related biometrics (e.g., glucose time-in-range, waist-hip ratio) and how providing medically tailored meals promotes engagement in diabetes education and drives information-seeking behavior. Secondary purposes are to characterize the relationship between information-seeking behaviors and glycemic control; to characterize the relationship between psychometric survey results and program engagement, biometrics, and information-seeking behaviors; and to understand how meal provision and materials influence program satisfaction and adherence to healthy diabetes-related behaviors.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
41
Healthy-lifestyle and diabetes-related virtual education (text and videos)
breakfast, lunch, and dinner adhering to the longevity diet macro-nutrient profiles
calls with coach and/or nutritionist, access to Facebook community support group
OptumLabs
Minnetonka, Minnesota, United States
Change in mean glucose time in range from baseline at Week 6
Percentage of time estimated glucose value (EGV) from continuous glucose monitor (CGM) is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results
Time frame: Week 0 and Week 6
Change in mean glucose time in range from baseline at Week 12
Percentage of time estimated glucose value (EGV) from CGM is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results
Time frame: Week 0 and Week 12
Change in mean glucose time in range from baseline at Week 16
Percentage of time estimated glucose value (EGV) from CGM is between 70 mg/dL and 180 mg/dL, measured daily with weekly composite results
Time frame: Week 0 and Week 16
Change in CGM-derived glucose features from baseline
Average of EGVs, percentage time above and below range (\< 70 mg/dL or \>180 mg/dL), and glucose variability (standard deviation of EGVs), measured via daily with weekly composite results
Time frame: Week 0, Week 6, Week 12, and Week 16
Change in blood test results from baseline
Difference in measurements of HbA1c, HDL cholesterol, total cholesterol, LDL cholesterol, triglycerides, and high-sensitivity C-reactive protein (hs-CRP) obtained from blood tests
Time frame: Week 0, Week 12
Change in self-reported waist-to-hip ratio
waist circumference, hip circumference, self-reported weekly; calculated by dividing the waist circumference by the hip circumference
Time frame: Weekly, Weeks 0-12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in self-reported blood pressure
blood pressure, self-reported weekly
Time frame: Weekly, Weeks 0-12